Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older—A Population-Based Cohort Study

This population-based cohort study evaluates the risk of cardiac arrhythmia and other cardiovascular events in patients 66 years or older receiving the β3-adrenoceptor agonist mirabegron.

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Intern Med
Main Authors: Tadrous, Mina, Matta, Rano, Greaves, Simon, Herschorn, Sender, Mamdani, Muhammad M., Juurlink, David N., Gomes, Tara
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Research Letter
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6632155/
https://ncbi.nlm.nih.gov/pubmed/31305875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.2011
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki